Starling Oncology, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Starling Oncology, Inc. (STLN) had Lessee, Operating Lease, Liability, to be Paid, Year One of $7.95 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $7.95M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $8.02M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $8.63M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $8.59M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $7.95M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $8.02M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $8.63M 10-K · filed 2026-03-12 |
| 2025-09-30 | $8.59M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $8.40M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $8.06M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $8.47M 10-K · filed 2025-03-26 |
| 2024-09-30 | $8.46M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $8.10M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $7.83M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $8.18M 10-K · filed 2024-03-28 |
| 2023-09-30 | $7.73M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $7.61M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $6.56M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $6.64M 10-K · filed 2023-03-16 |
| 2022-09-30 | $6.44M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $4.96M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $4.73M 10-Q · filed 2022-05-10 |